Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
 2016 - Forecasts to 2020 - EconoTimes)
Dublin, Sept. 05, 2016 -- Research and Markets has announced the addition of the "Global Market Report on Efungumab 2016" report to their offering.
The Global Market Report on Efungumab provides comprehensive data on Efungumab global and regional markets including Europe, Asia, North America, Latin America, etc. The report captures Efungumab market trends and pays close attention to Efungumab
The report is broken into three main parts including manufacturing methods & technology development, market landscape & trend analysis, and distribution policy.
In the manufacturing methods & technology development section, the main manufacturing methods of Efungumab are introduced.
Key Topics Covered:
Part 1: Introduction of Efungumab
Chapter 1: Brief Introduction of Efungumab
Chapter 2: Product Identification
Chapter 3: Physical Properties
Chapter 4: Quality Specifications
Part 2: Manufacture Methods and Technology Development of Efungumab
Chapter 1: Introduction of Main Manufacture Methods
Chapter 2: Introduction of Patent Manufacture Methods
Chapter 3: New Progress on the Manufacture Technology
Part 3: Application of Efungumab
Chapter 1: Application Review
Chapter 2: End Products(Downstream Products) of Efungumab
Chapter 3: New Applications of Efungumab
Part 4: Production Situation of Efungumab
Chapter 1: Current Production Situation
Chapter 2: Manufacturers in China
Chapter 3: Manufacturers Outside of China
Chapter 4: Production Trend Analysis
Part 5: Market Situation of Efungumab
Chapter 1: Market Supply Status and Trend Forecast
Chapter 2: Downstream Consumer Market Analysis
Chapter 3: Supply and Demand Analysis and Forecast
Chapter 4: Price Analysis
Chapter 5: Import & Export Situation
Part 6: Distribution Policy of Efungumab
Chapter 1: Market Size in Major Use Segments
Chapter 2: Major End Users
Chapter 3: Potential Users
Part 7: Reference
For more information about this report visit http://www.researchandmarkets.com/research/p2xz7x/global_market
Related Topics: Chemicals
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
